ArticleCureus2026
Clinical Audit on Follow-Up Time of Patients Admitted With Acute Decompensated Heart Failure.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarly outpatient follow-up after hospital discharge is essential to reduce readmissions and improve outcomes in patients with acute decompensated heart failure (ADHF).
objectiveThis audit aims to assess whether patients admitted with ADHF receive outpatient follow-up within 14 days of discharge, in line with international guideline recommendations. METHODOLOGY: A prospective clinical audit was conducted at the Peshawar Institute of Cardiology, Pakistan, including 120 adult patients admitted with ADHF (60 in the initial audit and 60 in the re-audit). Patient demographics, planned and actual follow-up dates, the number of days between discharge and follow-up, attendance, and the kind of healthcare provider were all gathered from hospital admission records, discharge summaries, and outpatient clinic documents. Patients who passed away while in the hospital, were moved, released against medical advice, or had inadequate medical data were excluded. Following the first audit (March-May 2025), there was an intervention phase (June-July 2025) and a second audit (August-October 2025). Chi-square and paired t-tests were used to evaluate compliance with a 14-day follow-up (SPSS version 25, IBM Corp., Armonk, NY).
resultsThe mean age was 64.27 ± 11.76 years (initial audit) and 65.12 ± 10.45 years (re-audit), with 38 (63.33%) male patients initially and 36 (60%) in the re-audit. Follow-up documentation at discharge increased from 45 patients (75%) to 58 patients (96.67%). Compliance with 14-day follow-up improved from 32 patients (53.33%) to 55 patients (91.67%), follow-ups after 14 days decreased from 18 (30%) to three (5%), and non-attendance dropped from 10 (16.67%) to two (3.33%). The mean follow-up interval reduced from 12.43 ± 5.12 days to 8.97 ± 2.85 days.
conclusionTargeted interventions significantly improved timely post-discharge follow-up in patients with ADHF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.